American Well Corporation (AMWL)
NYSE: AMWL · IEX Real-Time Price · USD
0.520
-0.011 (-2.05%)
At close: May 2, 2024, 4:01 PM
0.530
+0.010 (1.85%)
After-hours: May 2, 2024, 7:54 PM EDT
American Well Revenue
American Well had revenue of $254.57M in the twelve months ending March 31, 2024, down -8.08% year-over-year. Revenue in the quarter ending March 31, 2024 was $59.52M, a -7.00% decrease year-over-year. In the year 2023, American Well had annual revenue of $259.05M, a decrease of -6.55%.
Revenue (ttm)
$254.57M
Revenue Growth
-8.08%
P/S Ratio
0.61
Revenue / Employee
$230,587
Employees
1,104
Market Cap
154.06M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 259.05M | -18.14M | -6.55% |
Dec 31, 2022 | 277.19M | 24.40M | 9.65% |
Dec 31, 2021 | 252.79M | 7.52M | 3.07% |
Dec 31, 2020 | 245.27M | 96.41M | 64.77% |
Dec 31, 2019 | 148.86M | 34.90M | 30.63% |
Dec 31, 2018 | 113.96M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Quipt Home Medical | 185.18M |
Seres Therapeutics | 126.33M |
InfuSystem Holdings | 125.79M |
Electromed | 51.69M |
ProQR Therapeutics | 10.58M |
Orchestra BioMed Holdings | 2.76M |
AMWL News
- 15 days ago - Amwell® to Report First Quarter 2024 Operating Results May 1 - GlobeNewsWire
- 4 weeks ago - Amwell Receives Continued Listing Standard Notice From NYSE - GlobeNewsWire
- 2 months ago - Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024 - GlobeNewsWire
- 2 months ago - Amwell Names Cynthia Horner, M.D., Chief Medical Officer - GlobeNewsWire
- 2 months ago - Amwell to Participate in Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - Amwell Executives to Take the Stage at ViVE 2024 - GlobeNewsWire
- 2 months ago - Amwell Announces Results for Fourth Quarter and Full Year 2023 - GlobeNewsWire
- 3 months ago - Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14 - GlobeNewsWire